← Oncology Approval Tracker

FDA DECISION ·

Pemetrexed Injection (Sandoz)

pemetrexed · Sandoz

FDA approvalNew formulationNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Pemetrexed injection for labeled nonsquamous NSCLC regimens including initial pembrolizumab plus platinum in metastatic disease without EGFR or ALK aberrations, and cisplatin combination treatment for malignant pleural mesothelioma.

LAMPGEN ANALYSIS

Why it matters

The approval adds a product-specific injectable option for established pemetrexed treatment settings.

What research teams should watch

Verify the precise product, permitted partners, supplementation, renal function, and preparation steps.

PRIMARY RECORDS

Sources